English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sir, We are writing in response to an article entitled ‘Antifungal therapy: drug–drug interactions at your fingertips’, which was published online on 8 November 2015. The article highlights the compilation of adverse drug–drug interactions (DDIs) with antifungal medicines as a knowledge database. They describe the construction of a database online and the development of a smartphone app to access the data for paired DDIs and antifungal drugs. The paper has omitted to mention a similar and pre-existing database, which was developed and made available online in 2012, using similar data sources. It also omitted reference to two smartphone apps for assessing DDIs with antifungal medicines, which have been available since early 2013. All these are free resources; both apps, named ‘Antifungal Interactions’, are available for Android or iOS platforms. The apps and the database have been presented at several international conferences. There are of course differences in some content and in the presentation of the app by Lempers and Brüggemann and our apps, but there are also some other important points to highlight:

Antifungal therapy: drug–drug interactions at your fingertips—authors' response